JP2008537778A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008537778A5 JP2008537778A5 JP2008504275A JP2008504275A JP2008537778A5 JP 2008537778 A5 JP2008537778 A5 JP 2008537778A5 JP 2008504275 A JP2008504275 A JP 2008504275A JP 2008504275 A JP2008504275 A JP 2008504275A JP 2008537778 A5 JP2008537778 A5 JP 2008537778A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- kit according
- vitamin receptor
- antibody
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000035029 vitamin receptors Human genes 0.000 claims 12
- 108091005463 vitamin receptors Proteins 0.000 claims 12
- 210000004027 cell Anatomy 0.000 claims 10
- 239000003814 drug Substances 0.000 claims 9
- 206010028980 Neoplasm Diseases 0.000 claims 8
- 201000011510 cancer Diseases 0.000 claims 8
- 229940079593 drug Drugs 0.000 claims 6
- 230000008685 targeting Effects 0.000 claims 4
- 238000011282 treatment Methods 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000004393 prognosis Methods 0.000 claims 3
- 238000002560 therapeutic procedure Methods 0.000 claims 3
- 206010006187 Breast cancer Diseases 0.000 claims 2
- 208000026310 Breast neoplasm Diseases 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000001000 micrograph Methods 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000008839 Kidney Neoplasms Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 208000034578 Multiple myelomas Diseases 0.000 claims 1
- 206010033128 Ovarian cancer Diseases 0.000 claims 1
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010038389 Renal cancer Diseases 0.000 claims 1
- 208000002495 Uterine Neoplasms Diseases 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000002596 correlated effect Effects 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 102000006815 folate receptor Human genes 0.000 claims 1
- 108020005243 folate receptor Proteins 0.000 claims 1
- 238000011532 immunohistochemical staining Methods 0.000 claims 1
- 201000010982 kidney cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 210000001165 lymph node Anatomy 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 238000010186 staining Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 238000011269 treatment regimen Methods 0.000 claims 1
- 206010046766 uterine cancer Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66643005P | 2005-03-30 | 2005-03-30 | |
| PCT/US2006/011376 WO2006105141A1 (en) | 2005-03-30 | 2006-03-30 | Method for cancer prognosis using cellular folate vitamin receptor quantification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008537778A JP2008537778A (ja) | 2008-09-25 |
| JP2008537778A5 true JP2008537778A5 (https=) | 2009-05-14 |
Family
ID=36754569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008504275A Withdrawn JP2008537778A (ja) | 2005-03-30 | 2006-03-30 | 細胞の葉酸ビタミン受容体の定量化による癌予後診断法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090081710A1 (https=) |
| EP (2) | EP1864133B1 (https=) |
| JP (1) | JP2008537778A (https=) |
| CN (1) | CN101203759A (https=) |
| AT (1) | ATE460668T1 (https=) |
| AU (1) | AU2006230219A1 (https=) |
| CA (1) | CA2602585A1 (https=) |
| DE (1) | DE602006012816D1 (https=) |
| RU (1) | RU2007139912A (https=) |
| WO (1) | WO2006105141A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1389209B1 (en) | 2001-04-24 | 2009-04-08 | Purdue Research Foundation | Folate mimetics and folate-receptor binding conjugates thereof |
| WO2003097647A1 (en) | 2002-05-15 | 2003-11-27 | Endocyte, Inc. | Vitamin-mitomycin conjugates |
| DK1592457T3 (da) | 2003-01-27 | 2012-10-22 | Endocyte Inc | Folat-vinblastin-konjugat som lægemiddel |
| CA2556027C (en) | 2004-02-12 | 2015-11-24 | Morphotek, Inc. | Monoclonal antibodies that specifically block biological activity of a tumor antigen |
| JP5149620B2 (ja) | 2004-07-23 | 2013-02-20 | エンドサイト，インコーポレイテッド | ２価リンカーおよびその結合体 |
| EP1863816B1 (en) | 2005-03-16 | 2014-06-25 | Endocyte, Inc. | Synthesis and purification of pteroic acid and conjugates thereof |
| EP2172487A1 (en) | 2005-04-22 | 2010-04-07 | Morphotek Inc. | Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| AU2006279304A1 (en) | 2005-08-19 | 2007-02-22 | Endocyte, Inc. | Multi-drug ligand conjugates |
| WO2008101231A2 (en) | 2007-02-16 | 2008-08-21 | Endocyte, Inc. | Methods and compositions for treating and diagnosing kidney disease |
| CN104127878A (zh) | 2007-03-14 | 2014-11-05 | 恩多塞特公司 | 结合配体连接的微管溶素递药缀合物 |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| BRPI0812970A2 (pt) | 2007-06-25 | 2019-09-24 | Endocyte Inc | conjugados contendo espaçadores hidrofílicos |
| US9187521B2 (en) | 2007-10-25 | 2015-11-17 | Endocyte, Inc. | Tubulysins and processes for preparing |
| EP2460013A4 (en) * | 2009-07-31 | 2013-04-03 | Endocyte Inc | ON FOLLOWING DIAGNOSIS AND TREATMENT |
| CN103037900B (zh) | 2010-02-24 | 2016-04-06 | 伊缪诺金公司 | 叶酸受体1抗体与免疫缀合物以及其用途 |
| AU2011323124C1 (en) * | 2010-11-05 | 2016-09-22 | Eisai Inc. | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| KR20130140033A (ko) * | 2010-11-12 | 2013-12-23 | 엔도사이트, 인코포레이티드 | 암을 치료하는 방법들 |
| IL281714B2 (en) * | 2011-04-01 | 2023-11-01 | Immunogen Inc | Methods for increasing the effectiveness of FOLR1 cancer therapy |
| PL2731972T3 (pl) | 2011-07-15 | 2018-06-29 | Eisai R&D Management Co., Ltd. | Przeciwciała skierowane przeciwko receptorowi folianowemu alfa i ich zastosowania |
| US10080805B2 (en) | 2012-02-24 | 2018-09-25 | Purdue Research Foundation | Cholecystokinin B receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| HUE049693T2 (hu) | 2012-08-31 | 2020-10-28 | Immunogen Inc | Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására |
| CN102861020A (zh) * | 2012-09-25 | 2013-01-09 | 上海交通大学医学院附属仁济医院 | 叶酸在制备预防大肠腺瘤初发药物中的应用 |
| EP2908818A4 (en) | 2012-10-16 | 2016-07-13 | Endocyte Inc | CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE |
| US20140154702A1 (en) * | 2012-11-30 | 2014-06-05 | Endocyte, Inc. | Methods For Treating Cancer Using Combination Therapies |
| AU2014312086B2 (en) | 2013-08-30 | 2020-03-12 | Immunogen, Inc. | Antibodies and assays for detection of folate receptor 1 |
| IL298044B2 (en) * | 2013-10-08 | 2024-11-01 | Immunogen Inc | Dosing regimens of anti-FOLR1 immunoconjugate |
| WO2015077303A1 (en) | 2013-11-19 | 2015-05-28 | Purdue Research Foundation | Patient selection method for inflammation |
| JP6246030B2 (ja) * | 2014-03-12 | 2017-12-13 | 東芝メディカルシステムズ株式会社 | 病理染色装置及び病理染色方法 |
| AU2016323968B2 (en) | 2015-09-17 | 2023-07-06 | Immunogen, Inc. | Therapeutic combinations comprising anti-FOLR1 immunoconjugates |
| US11313868B2 (en) * | 2016-06-14 | 2022-04-26 | Board Of Regents, The University Of Texas System | Methods of detecting anti-folic acid antibodies and uses thereof |
| CN106483282B (zh) * | 2016-09-29 | 2018-08-31 | 北京世纪沃德生物科技有限公司 | 一种抗原稳定剂及其制备方法与应用 |
| US10822410B2 (en) | 2016-11-23 | 2020-11-03 | Eisai R&D Management Co., Ltd. | Anti-folate receptor alpha antibodies and uses thereof |
| CA3194182A1 (en) * | 2020-09-12 | 2022-03-17 | Medimmune Limited | A scoring method for an anti-b7h4 antibody-drug conjugate therapy |
| CN117741149A (zh) * | 2024-02-19 | 2024-03-22 | 卡秋(江苏)生物科技有限公司 | 一种用于卵巢癌细胞叶酸受体α的检测试剂盒及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5989838A (en) * | 1992-03-11 | 1999-11-23 | Institute Of Virology, Slovak Academy Of Sciences | Immunological methods of detecting MN proteins and MN polypeptides |
| US6218529B1 (en) * | 1995-07-31 | 2001-04-17 | Urocor, Inc. | Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer |
| US5846739A (en) | 1995-12-05 | 1998-12-08 | Wisconsin Alumni Research Foundation | Immunohistochemical detection assay for carcinoma proliferative status |
| US6358682B1 (en) | 1998-01-26 | 2002-03-19 | Ventana Medical Systems, Inc. | Method and kit for the prognostication of breast cancer |
| PL211872B1 (pl) | 2000-03-31 | 2012-07-31 | Purdue Research Foundation | Kompozycja farmaceutyczna |
| KR20040053136A (ko) * | 2001-09-28 | 2004-06-23 | 펄듀 리서치 파운데이션 | 리간드-면역원 공액체를 이용한 치료 방법 |
| JP2005532296A (ja) * | 2002-04-19 | 2005-10-27 | エンドサイト，インコーポレイテッド | アジュバントにより増強される免疫療法 |
| WO2003097647A1 (en) | 2002-05-15 | 2003-11-27 | Endocyte, Inc. | Vitamin-mitomycin conjugates |
| DK1592457T3 (da) * | 2003-01-27 | 2012-10-22 | Endocyte Inc | Folat-vinblastin-konjugat som lægemiddel |
-
2006
- 2006-03-30 AT AT06739883T patent/ATE460668T1/de not_active IP Right Cessation
- 2006-03-30 EP EP06739883A patent/EP1864133B1/en not_active Expired - Lifetime
- 2006-03-30 DE DE602006012816T patent/DE602006012816D1/de not_active Expired - Lifetime
- 2006-03-30 CA CA002602585A patent/CA2602585A1/en not_active Abandoned
- 2006-03-30 US US11/887,438 patent/US20090081710A1/en not_active Abandoned
- 2006-03-30 EP EP10155913A patent/EP2199796A1/en not_active Withdrawn
- 2006-03-30 JP JP2008504275A patent/JP2008537778A/ja not_active Withdrawn
- 2006-03-30 RU RU2007139912/15A patent/RU2007139912A/ru unknown
- 2006-03-30 CN CNA2006800192306A patent/CN101203759A/zh active Pending
- 2006-03-30 WO PCT/US2006/011376 patent/WO2006105141A1/en not_active Ceased
- 2006-03-30 AU AU2006230219A patent/AU2006230219A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008537778A5 (https=) | ||
| Singh et al. | TNBC: potential targeting of multiple receptors for a therapeutic breakthrough, nanomedicine, and immunotherapy | |
| Mowery et al. | Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial | |
| Carthon et al. | Epidermal growth factor receptor‐targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis | |
| Harari et al. | Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234 | |
| Paoluzzi et al. | Response to anti-PD1 therapy with nivolumab in metastatic sarcomas | |
| Tran et al. | Survival comparison between glioblastoma multiforme and other incurable cancers | |
| BRPI0916138A2 (pt) | "método de tratamento de um sujeito diagnosticado com câncer de mama localmente, kit para tratar câncer de mama metastático em um sujeito humano, uso de um anticorpo antivegf na fabricação de um medicamento para tratar câncer de mama localmente recidivado ou metastático em um sujeito e anticorpo anti-vegf para uso em um método de tratamento de câncer de mama localmente recidivado ou metastático em um sujeito" | |
| RU2007139912A (ru) | Способ прогнозирования течения рака на основе количественного анализа клеточного рецептора витамина фолата | |
| JP2008507530A5 (https=) | ||
| Savona et al. | Phase I trial of selinexor (KPT-330), a first-in-class oral selective inhibitor of nuclear export (SINE) in patients (pts) with advanced acute myelogenous leukemia (AML) | |
| NZ601580A (en) | Therapeutic methods using anti-cd200 antibodies | |
| WO2005080431A3 (en) | Monoclonal antibodies that specifically bind to folate receptor alpha | |
| RU2016109811A (ru) | Лечение рака комбинацией антагониста pd-1 и динациклиба | |
| DE602007013282D1 (de) | Monoklonale antikörper gegen den humanen anti-müllerian-hormonrezeptor vom typ ii (amhr-ii) | |
| UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
| RU2013106938A (ru) | Биомаркеры в плазме крови, предназначенные для комбинированных терапий с использованием бевацизумаба при лечении рака молочной железы | |
| Sahin et al. | Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors | |
| JP2013536236A5 (https=) | ||
| JP2013520431A5 (https=) | ||
| Abi-Jaoudeh et al. | Personalized oncology in interventional radiology | |
| Nassim et al. | Combining mTOR inhibition with radiation improves antitumor activity in bladder cancer cells in vitro and in vivo: a novel strategy for treatment | |
| Cmelak | Current issues in combined modality therapy in locally advanced head and neck cancer | |
| Rendell et al. | Targeting tyrosine kinases in ovarian cancer: small molecule inhibitor and monoclonal antibody, where are we now? | |
| WO2008118733A3 (en) | Methods of treating cancer by administering human il-18 combinations |